Search Results

Comparison of the therapeutic effects of medication therapy, specific immunotherapy and anti-IgE (Omalizumab) in patients with hay fever.

• Authors : Rui Tang; Xiaohong Lyu; Yibo Hou

Subjects: ALLERGIC rhinitis; OMALIZUMAB; IMMUNOTHERAPY

• Source: Frontiers in Immunology; 2024, p1-7, 7p

Record details

Omalizumab in combination with subcutaneous immunotherapy for the treatment of multiple allergies associated with attention-deficit/hyperactivity disorder: a case report and a literature review.

• Authors : Bo Ding; Yanming Lu

Subjects: ATTENTION-deficit hyperactivity disorder; LITERATURE reviews; OMALIZUMAB

• Source: Frontiers in Pharmacology; 2024, p01-08, 8p

Record details

Venom immunotherapy and difficulties encountered before and during immunotherapy: Double sensitization, systemic reactions, treatment with omalizumab, and high dose VIT.

• Authors : PAÇACI ÇETİN, Gülden¹ ; YILMAZ, İnsu¹; TÜRK, Murat²

Subjects: *OMALIZUMAB; *VENOM; *BLOOD groups

• Source: Turkish Journal of Medical Sciences. 2022, Vol. 52 Issue 4, p1223-1234. 12p.

Record details

Combination of omalizumab with allergen immunotherapy versus immunotherapy alone for allergic diseases: A meta‐analysis of randomized controlled trials.

• Authors : Zhang, Ying‐Ying¹ (AUTHOR); Zhang, Min¹ (AUTHOR); Zhang, Jia‐Qi¹ (AUTHOR)

Subjects: *ALLERGIES; *OMALIZUMAB; *IMMUNOTHERAPY

• Source: International Forum of Allergy & Rhinology. Apr2024, Vol. 14 Issue 4, p794-806. 13p.

Record details

Phase 2, randomized multi oral immunotherapy with omalizumab 'real life' study.

• Authors : Sindher, Sayantani B.; Kumar, Divya; Cao, Shu

Subjects: OMALIZUMAB; IMMUNOTHERAPY; SUBLINGUAL immunotherapy

• Source: Allergy; Jun2022, Vol. 77 Issue 6, p1873-1884, 12p

Record details

Failed oral immunotherapy should be considered as a risk factor for fatal anaphylaxis, and omalizumab treatment considered.

• Authors : Nicolardi, Francesca; Corona, Federica; Badina, Laura

Subjects: THERAPEUTIC use of monoclonal antibodies; RISK assessment; IMMUNOTHERAPY

• Source: Italian Journal of Pediatrics; 11/9/2024, Vol. 50 Issue 1, p1-2, 2p

Record details

Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumab.

• Authors : Manohar, Monali; Dunham, Diane; Gupta, Sheena

Subjects: IMMUNOTHERAPY; OMALIZUMAB; T cells

• Source: Allergy; Sep2021, Vol. 76 Issue 9, p2809-2826, 18p

Record details

Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy.

• Authors : Langlois, Alexandra; Lavergne, Marie-Hélène; Leroux, Hélène

Subjects: FOOD allergy; IMMUNOTHERAPY; TREATMENT effectivenessCANADA

• Source: Allergy, Asthma & Clinical Immunology; 5/17/2020, Vol. 16 Issue 1, p1-16, 16p

Record details

A case of cow's milk allergy treated with rush oral immunotherapy with omalizumab.

• Authors : Iwasaki, Yasushi; Okada, Yuki; Imai, Tananori

• Source: Pediatrics International; Jan2024, Vol. 66 Issue 1, p1-2, 2p

Record details

The use of omalizumab in allergen immunotherapy.

• Authors : Dantzer, J. A.; Wood, R. A.

Subjects: ANTI-immunoglobulin E autoantibodies; ASTHMA treatment; TREATMENT of urticaria

• Source: Clinical & Experimental Allergy; Mar2018, Vol. 48 Issue 3, p232-240, 9p, 2 Charts

Record details